HOUSTON, June 20, 2013 /PRNewswire/ -- The Lanier Law Firm has earned recognition in the prestigious 2013 U.S. edition of The Legal 500 based on the firm's work for plaintiffs in mass tort and class action litigation involving pharmaceutical drugs and medical devices.
The Legal 500 directory is published by LegalEase, a worldwide provider of information on elite law firms. The group compiles the annual Legal 500 listing of the nation's leading law firms based on peer recommendations and client interviews.
The Lanier Law Firm was one of four plaintiffs firms in the nation recognized in The Legal 500 as an elite "Top Tier Firm" in Mass Tort and Class Action: Pharmaceuticals and Medical Devices. The publication noted the firm's leading work in litigation involving DePuy hip replacements, Yaz/Yasmin, Chantix, Paxil and Levaquin.
Firm founder W. Mark Lanier was highlighted for his success in Vioxx litigation, and is one of seven attorneys across the country singled out as Leading Lawyers for mass tort litigation. Noted attorney Richard D. "Rick" Meadow, chair of the firm's pharmaceutical litigation division, also was praised for his role as co-litigation counsel for the Levaquin litigation in New Jersey.
With offices in Houston, Los Angeles and New York, The Lanier Law Firm is committed to addressing client concerns with effective and innovative solutions in courtrooms across the country. The firm is composed of outstanding trial attorneys with decades of experience handling cases involving pharmaceutical liability, asbestos exposure, intellectual property, business litigation, products liability, maritime law, bad faith insurance claims and sports and entertainment law.
For more information on The Lanier Law Firm's Legal 500 honor, please contact J.D. Cargill at 713-659-5200.
SOURCE The Lanier Law Firm